June 19, 2019
ELI LILLY (I4V-MC-JAJA)
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis
Read More
June 19, 2019
ELI LILLY (I8F-MC-GPGH)
A Randomized, Phase 3, Open-Label Trial Comparing the effect of LY3298176 versus Titrated Insulin Degludec…
Read More
June 19, 2019
INTERCEPT PHARMACEUTICALS, INC. (747-304)
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of…
Read More
